JP2021508507A5 - - Google Patents

Download PDF

Info

Publication number
JP2021508507A5
JP2021508507A5 JP2020528340A JP2020528340A JP2021508507A5 JP 2021508507 A5 JP2021508507 A5 JP 2021508507A5 JP 2020528340 A JP2020528340 A JP 2020528340A JP 2020528340 A JP2020528340 A JP 2020528340A JP 2021508507 A5 JP2021508507 A5 JP 2021508507A5
Authority
JP
Japan
Prior art keywords
spray
dried
thrombin
dried thrombin
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020528340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021508507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/066838 external-priority patent/WO2019133440A1/en
Publication of JP2021508507A publication Critical patent/JP2021508507A/ja
Publication of JP2021508507A5 publication Critical patent/JP2021508507A5/ja
Withdrawn legal-status Critical Current

Links

JP2020528340A 2017-12-29 2018-12-20 噴霧乾燥トロンビン並びに噴霧乾燥トロンビンを使用及び製造する方法 Withdrawn JP2021508507A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762611963P 2017-12-29 2017-12-29
US62/611,963 2017-12-29
US201862771936P 2018-11-27 2018-11-27
US62/771,936 2018-11-27
PCT/US2018/066838 WO2019133440A1 (en) 2017-12-29 2018-12-20 Spray-dried thrombin and methods of using and making spray-dried thrombin

Publications (2)

Publication Number Publication Date
JP2021508507A JP2021508507A (ja) 2021-03-11
JP2021508507A5 true JP2021508507A5 (https=) 2022-01-11

Family

ID=65024106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020528340A Withdrawn JP2021508507A (ja) 2017-12-29 2018-12-20 噴霧乾燥トロンビン並びに噴霧乾燥トロンビンを使用及び製造する方法

Country Status (12)

Country Link
US (1) US11583610B2 (https=)
EP (1) EP3731885B1 (https=)
JP (1) JP2021508507A (https=)
KR (1) KR20200105680A (https=)
CN (1) CN111787958A (https=)
AU (1) AU2018396037A1 (https=)
BR (1) BR112020011034A2 (https=)
CA (1) CA3083064A1 (https=)
ES (1) ES3058243T3 (https=)
MX (1) MX2020006856A (https=)
SG (1) SG11202005231RA (https=)
WO (1) WO2019133440A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12343385B2 (en) 2021-11-29 2025-07-01 Baxter International Inc. Hemostat reconstitution methods and devices
CN118785918A (zh) 2021-12-23 2024-10-15 广州倍绣生物技术有限公司 喷雾干燥的凝血酶

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE19859611C2 (de) * 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
ES2682302T3 (es) 2010-06-01 2018-09-19 Baxter International Inc Proceso para la producción de composiciones hemostáticas secas y estables
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) * 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
CN107754005B (zh) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 止血组合物及其制造方法

Similar Documents

Publication Publication Date Title
IL273135B2 (en) Tissue scaffold materials for tissue regeneration and methods of making
WO2017100700A3 (en) Peptides for renal therapy
JP2013514093A5 (https=)
EP4331509A3 (en) Devices for left atrial appendage closure
WO2014040026A3 (en) Amniotic membrane and its use in wound healing and tissue engineering constructs
JP2015164549A5 (https=)
JP2018506286A5 (https=)
RU2017116973A (ru) Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса
EP4349359A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
JP2021508507A5 (https=)
EA201891164A1 (ru) Композиции и способы получения белковых микрочастиц
RU2017132860A (ru) Коллагенсодержащая медицинская салфетка для ран и способ её изготовления
JP2019524648A5 (https=)
MX2019014448A (es) Inmunoglobulinas de enlace a mmp13.
WO2018201260A8 (en) Biocompatible hydrogel compositions and uses thereof
EA201790361A1 (ru) Доставка биоактивных антиоксидантов, заключенных в нанокапсулы
JP2016527979A5 (https=)
JP2021524436A5 (https=)
HRP20230336T1 (hr) Sastavi protiv krvarenja
JP2016515123A5 (https=)
MX2015017058A (es) Combinaciones farmaceuticas de un inhibidor de pi3k y un agente de desestabilizacion de microtubulos.
JP2017513944A5 (https=)
WO2017049009A8 (en) Cystine knot scaffold platform
JP2016513658A5 (https=)
MY172503A (en) Activating adiponectin by casein hydrolysate